期刊文献+

和肽素在急危重症中的临床应用进展 被引量:11

原文传递
导出
摘要 和肽素是由39个氨基酸组成的多肽,它与精氨酸加压素(arginine vasopress!n,AVP)一样来自于精氨酸加压素前体。和肽素的具体功能目前尚不明确,目前多认为其可能通过修正精氨酸加压素前体结构以提高蛋白水解及AVP形成的效率。近年来关于和肽素临床应用的研究日益增多,相关研究结果提示血浆和肽素水平与多种临床急危重症的严重程度及预后密切相关,本文就和肽素在急危重症中的应用作一综述。
作者 祝建勇
出处 《中华危重症医学杂志(电子版)》 CAS 2012年第1期40-42,共3页 Chinese Journal of Critical Care Medicine:Electronic Edition
  • 相关文献

参考文献19

  • 1Land H,Schutz G,Schmale H. Nucleotide sequence of cloned cDNA encoding bovine arginine vasopressin-neurophysin II precursor[J].Nature,1982,(5847):299-303.doi:10.1038/295299a0.
  • 2Barat C,Simpson L,Breslow E. Properties of human vasopressin precursor constructs:inefficient monomer folding in the absence of copeptin as a potential contributor to diabetes insipidus[J].Biochemistry,2004,(25):8191-8203.doi:10.1021/bi0400094.
  • 3Reichlin T,Hochholzer W,Stelzig C. Incremental value of copeptin for rapid rule out of acute myocardial infarction[J].Journal of the American College of Cardiology,2009,(01):60-68.doi:10.1016/j.jacc.2009.01.076.
  • 4Keller T,Tzikas S,Zeller T. Copeptin improves early diagnosis of acute myocardial infarction[J].Journal of the American College of Cardiology,2010,(19):2096-2106.doi:10.1016/j.jacc.2010.01.029.
  • 5Chenevier-Gobeaux C,Freund Y,Claessens YE. Copeptin for rapid rule out of acute myocardial infarction in emergency department[J].International Journal of Cardiology,2011.
  • 6Khan SQ,Dhillon OS,O'Brien RJ. C-terminal provasopressin (copeptin) as a novel and prognostic marker in acute myocardial infarction:Leicester Acute Myocardial Infarction Peptide (LAMP) study[J].Circulation,2007,(16):2103-2110.
  • 7Voors AA,von Haehling S,Anker SD. C-terminal provasopressin (copeptin) is a strong prognostic marker in patients with heart failure after an acute myocardial infarction:results from the OPTIMAAL study[J].European Heart Journal,2009,(10):1187-1194.doi:10.1093/eurheartj/ehp098.
  • 8Narayan H,Dhillon OS,Quinn PA. C-terminal provasopressin (copeptin) as a prognostic marker after acute non-ST elevation myocardial infarction:Leicester Acute Myocardial Infarction Peptide II (LAMP II) study[J].Clinical Science(London),2011,(02):79-89.doi:10.1042/CS20100564.
  • 9Gegenhuber A,Struck J,Dieplinger B. Comparative evaluation of B-type natriuretic peptide,mid-regional pro-A-type natriuretic peptide,mid-regional pro-adrenomedullin,and copeptin to predict 1-year mortality in patients with acute destabilized heart failure[J].Journal of Cardiac Failure,2007,(01):42-49.doi:10.1016/j.cardfail.2006.09.004.
  • 10Miller WL,Hartman KA,Grill DE. Serial measurements of midregion proANP and copeptin in ambulatory patients with heart failure:incremental prognostic value of novel biomarkers in heart failure[J].Heart,2012,(05):389-394.doi:10.1136/heartjnl-2011-300823.

同被引文献164

引证文献11

二级引证文献47

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部